5 Key Takeaways

• 1

  The complexity of drug molecules has increased, leading to a rise in poorly soluble drugs in company pipelines.

• 2

  New technologies like AI and structure-based drug design are enabling the discovery of previously undruggable targets.

• 3

  KinetiSol technology addresses solubility issues by using mechanical energy instead of organic solvents or high heat.

• 4

  The crystal structure of drugs poses significant barriers to dissolution and absorption, complicating drug delivery.

• 5

  In silico discovery tools and advanced delivery methods are expanding treatment options for chronic diseases, especially in oncology.